Results 131 to 140 of about 316,189 (194)
Journal of the Peripheral Nervous System, Volume 31, Issue 3, September 2026.ABSTRACT Background and Aims Chronic axonal polyneuropathy is a common disorder that often remains undiagnosed. Early detection may enhance treatment of underlying risk factors and prevent long‐term complications. The Erasmus‐Polyneuropathy symptom score (E‐PSS) is a simple and rapid screening tool, consisting of six questions (score ranges 0–14). This
Noor E. Taams +9 more
wiley +1 more source
European Journal of Pain, Volume 30, Issue 8, September 2026.
Didier Bouhassira, Nadine Attal
wiley +1 more source
Journal of the Peripheral Nervous System, Volume 31, Issue 3, September 2026.ABSTRACT Background and Aims Small fiber neuropathy (SFN) is a peripheral neuropathy causing neuropathic pain, reduced quality of life (QoL), and high societal costs. Previous studies assessed these societal costs before a definitive diagnosis was established, leaving it unclear whether diagnostic confirmation affects costs, pain intensity, or QoL ...
Dennis Kool +7 more
wiley +1 more source
Journal of the Peripheral Nervous System, Volume 31, Issue 3, September 2026.ABSTRACT Background and Aim Neuropathic pain (NeuP) is widely underdiagnosed, and treatment‐related adverse events often drive nonadherence. We investigated the probable NeuP prevalence, symptoms recognition, and treatment preferences among the general population in Malaysia.
Wee‐Kiat Tan +11 more
wiley +1 more source
[Diabetic peripheral polyneuropathy].
Problemy endokrinologii, 1977 Pain, tactile, vibration and temperature sensitivity, and also electroexcitability of individual nerves were determined. Neuropathy incidence was almost the same among males and females. There was found no association between neuropathy and excessive weight of the patients and the type of treatment. The frequency of affection increased with the advance
Sh G, Iuldashev, A M, Kaĭlakov
openaire +1 more source
Neurophysiological Characteristics of Nitrous Oxide‐Induced Polyneuropathy: A Case Series
Journal of the Peripheral Nervous System, Volume 31, Issue 3, September 2026.ABSTRACT Background Nitrous oxide (N2O) misuse is a growing health concern, with N2O‐induced neurological disorders increasingly reported across Europe. Among these, N2O‐induced polyneuropathy (PNP) can lead to permanent deficits, yet its neurophysiological characteristics remain inconsistently described.
Tanya Elisabeth Bentley +3 more
wiley +1 more source
Journal of the Peripheral Nervous System, Volume 31, Issue 3, September 2026.ABSTRACT Background and Aims The Val122Ile ATTR Amyloidosis has traditionally been linked to cardiac manifestations. Recent studies suggest that neuropathy may be relevant. In this study, we characterized its peripheral nerve manifestations in depth. Methods This was a national, multicenter, observational, retrospective study.
Anna Paula Paranhos +16 more
wiley +1 more source
Possibilities and importance of physiotherapy in diabetic polyneuropathy
, 2015 This bachelor thesis focuses on issues in diabetic polyneuropathy. Diabetic polyneuropathy is one of the most frequent chronical complications in internal disease diabetes mellitus. The point is that the functions of peripheral nerves are being destroyed
ŠTÍCHOVÁ, Kateřina
core
Comparing the Diagnostic Characteristics of Neuropathy Questionnaires in Adults With Obesity
Journal of the Peripheral Nervous System, Volume 31, Issue 3, September 2026.ABSTRACT Aim To compare the diagnostic characteristics of three peripheral neuropathy (PN) patient‐completed questionnaires. Methods We recruited participants with obesity from a previously completed randomized controlled trial. Patient‐completed PN questionnaires included the Michigan Neuropathy Screening Instrument questionnaire (MNSIq), the Diabetic
Nicholas Heaton +7 more
wiley +1 more source
Journal of the Peripheral Nervous System, Volume 31, Issue 3, September 2026.ABSTRACT Background and Aims In the NEURO‐TTRansform clinical trial (NCT04136184), eplontersen improved neuropathy impairment and quality of life (QoL) through Week 66 versus the NEURO‐TTR historical placebo in patients with hereditary transthyretin amyloidosis with polyneuropathy (ATTRv‐PN).
Thomas H. Brannagan III +12 more
wiley +1 more source